Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Vaxcyte, Inc. (PCVX) had Return on Equity of -28.55% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-766.63M |
|
-- |
|
-- |
|
$923.67M |
|
$-923.67M |
|
$157.05M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-766.63M |
|
$-923.67M |
|
$-913.25M |
|
136.09M |
|
136.09M |
|
$-5.63 |
|
$-5.63 |
|
| Balance Sheet Financials | |
$1.63B |
|
$257.37M |
|
$1.38B |
|
$3.00B |
|
$205.75M |
|
-- |
|
$111.46M |
|
$317.21M |
|
$2.69B |
|
$2.69B |
|
$2.69B |
|
131.06M |
|
| Cash Flow Statement Financials | |
$-655.58M |
|
$437.35M |
|
$2.01M |
|
$389.19M |
|
$175.43M |
|
$-213.77M |
|
$138.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-669.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-28.55% |
-28.55% |
|
-25.53% |
|
-28.55% |
|
$20.49 |
|
$-4.92 |
|
$-4.82 |
|